Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Publication notes were updated to clarify that publications are provided voluntarily by the person entering information and pertain to the study results. The revision tag changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:17.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding status notice; study details and links remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:50.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Non-significant changes observed: The two screenshots show largely the same Study Details page with no core information added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:20:56.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Updated to v3.2.0 with an operational status notice; removed a specific disease resource (Cutaneous neuroendocrine carcinoma) and v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-06T06:55:13.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:26:10.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing v3.0.1, indicating a new release. The 'Back to Top' element was removed; otherwise, there are no changes to core content, pricing, stock, or time-sensitive information.
    Difference
    0.2%
    Check dated 2025-09-14T21:39:41.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.